explore -WSS

explore

author：hotspot 2025-09-07 08:42:39 - browse：5

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured.

So he’s seen the field’s highs and lows. Lately, there have been a lot of both, including at Pfizer, the company Cheng called home until this summer. The pharma brought three potentially powerful gene therapies for muscular dystrophy and hemophilia into late-stage trials but, in January, chose to abandon a large portfolio of early stage candidates that relied on the same technology: adeno-associated viruses, or AAVs, a group of small bugs that scientists spent two decades taming into a gene shipping system.

The move seemed emblematic. Across the industry, AAV companies have been struggling, either shelving programs or stopping work altogether, while investors shuttled money toward new technologies such as CRISPR and its various permutations. Longtime researchers feared promising drugs, particularly for ultra-rare diseases, might get lost in the shuffle.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： WHO recommends second malaria vaccine

WSS

Lawsuit highlights wrinkle for disputes over surprise medical bills

Will an HIV vaccine ever be a reality?

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

The stock market has soared this year, but will it last? Experts weigh in

The stock market has soared this year, but will it last? Experts weigh in

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

focus

explore

leisure time

The high cost of giving birth even with insurance

WHO recommends second malaria vaccine

Medicare proposal to cover medical devices draws a mixed reaction

Some top drug companies are starting to take action on climate

In Memoriam: Notable people who died in 2023

Dementia risk linked to living in disadvantaged areas: Study

Peter Hotez and the public health issue of online harassment

CDC picks Alphabet's Verily for wasterwater surveillance contract

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

In rare move, senator releases unverified FBI source report alleging Biden bribe

Wikipedia

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Caribou posts encouraging results on off

knowledge

focus

explore

entertainment